Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Gennery

Showing results (211-220 of 297) with videos related to

Pageof 30
Sort By:
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3<sup>+</sup> T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
Blood|October 4, 2003
Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002Andrew R Gennery, Khulood Khawaja, Paul Veys, et al.
Haematologica|March 4, 2017
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromeZhanna Shekhovtsova, Carmem Bonfim, Annalisa Ruggeri, et al.
Frontiers in Immunology|January 9, 2019
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working GroupSimon Bomken, Jutte van der Werff Ten Bosch, Andishe Attarbaschi, et al.
The Journal of Clinical Investigation|November 4, 2009
Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cellsMarjorie Côte, Mickaël M Ménager, Agathe Burgess, et al.
The Journal of Experimental Medicine|February 8, 2012
Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesisLikun Du, Roujun Peng, Andrea Björkman, et al.
Journal of Clinical Immunology|January 21, 2026
Correction to: An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disordersRebecca A Marsh, Kyle Hebert, Soyoung Kim, et al.
Journal of Clinical Immunology|July 16, 2023
An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked AgammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
Blood|April 9, 2010
Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantationVictoria Bordon, Andrew R Gennery, Mary A Slatter, et al.
Pageof 30

Showing results (211-220 of 297) with videos related to

Sort By:
Pageof 30
Transplantation and Cellular Therapy|December 16, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3<sup>+</sup> T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow GraftsSu Han Lum, Beki James, Giorgio Ottaviano, et al.
Blood|October 4, 2003
Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002Andrew R Gennery, Khulood Khawaja, Paul Veys, et al.
Haematologica|March 4, 2017
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromeZhanna Shekhovtsova, Carmem Bonfim, Annalisa Ruggeri, et al.
Frontiers in Immunology|January 9, 2019
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working GroupSimon Bomken, Jutte van der Werff Ten Bosch, Andishe Attarbaschi, et al.
The Journal of Clinical Investigation|November 4, 2009
Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cellsMarjorie Côte, Mickaël M Ménager, Agathe Burgess, et al.
The Journal of Experimental Medicine|February 8, 2012
Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesisLikun Du, Roujun Peng, Andrea Björkman, et al.
Journal of Clinical Immunology|January 21, 2026
Correction to: An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disordersRebecca A Marsh, Kyle Hebert, Soyoung Kim, et al.
Journal of Clinical Immunology|July 16, 2023
An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked AgammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
Blood|April 9, 2010
Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantationVictoria Bordon, Andrew R Gennery, Mary A Slatter, et al.
Pageof 30